PNEUMONIX AWARDED THE JOHNS HOPKINS TECH ACCELERATOR FUND GRANT

Recent Posts

PneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced...

PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development...